Outpatient percutaneous liver biopsy: still a good option.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 19712850.
- Also identified by DOI 10.1016/j.ejim.2009.02.002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
OBJECTIVE: To assess security of "blind" percutaneous liver biopsy as an ambulatory procedure. MATERIAL AND METHODS: Defining inclusion criteria, surveillance protocol, data from ultrasonography done 6 h after procedure and complications. RESULTS: We analysed 192 percutaneous liver biopsies done between 2000-2007. There were no major complications and only a small number of minor complications. There were no deaths related to the procedure. CONCLUSION: It is possible to perform percutaneous liver biopsy as an ambulatory procedure not expecting to find threatening complications.